首页 > 最新文献

Journal of Obesity & Metabolic Syndrome最新文献

英文 中文
Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61-9). 肝纤维化和脂肪变性在代谢综合征(J Obes Metab Syndr 2022;31:61-9)。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22049
Young-Gyun Seo
J Obes Metab Syndr 2022;31:350-351 Nonalcoholic fatty liver disease has a worldwide prevalence of 25%, which includes diseases ranging from steatosis to steatohepatitis, and has a bidirectional association with metabolic syndrome (MetS).1 Although a few studies have investigated the association between liver fibrosis and MetS, their findings have been controversial. A recent cohort study of a large patient-centered medical home found that a heavy burden of MetS components was associated with high or indeterminate risk for advanced fibrosis when noninvasive indices were used.2 The results of studies evaluating fibrosis confirmed by liver biopsy were different. MetS was not significantly related to advanced liver fibrosis in biopsy-proven metabolic dysfunction-associated fatty liver disease patients3 and MetS was not associated with hepatic fibrosis among individuals with hereditary hemochromatosis.4 Gangireddy et al.5 reported useful findings in an article entitled “Hepatic fibrosis and steatosis in metabolic syndrome.” In analysis using National Health and Nutrition Examination Survey (NHANES) data, 26% of the participants had steatosis; 7.5% had fibrosis; and 3.3% had fibrosis without steatosis. The adjusted odds ratios were 4.12 for steatosis, 3.34 for fibrosis, and 2.67 for fibrosis without steatosis in participants with MetS compared to those without. The strength of Gangireddy et al.’s study5 is that it was population-scale study conducted in the United States. It also has some strengths in that hepatic fibrosis and steatosis were evaluated through liver ultrasound. However, as mentioned in the paper, the fact that hepatic fibrosis and steatosis were not evaluated by liver biopsy is one limitation, and it is necessary to consider a method to address this weakness. Another limitation is that noninvasive indices were not used. By using hepatic fibrosis and steatosis indices such as fatty liver index6 and fibrosis-4 index7 instead of or in addition to liver ultrasound, which was employed only during specific years of the NHANES dataset, the study period could be significantly extended, and a large-scale evaluation of the general population would be possible. Nevertheless, as a study targeting the general population in the United States, Gangireddy et al.’s study5 is meaningful and proves a relationship between hepatic fibrosis and steatosis and MetS. Therefore, further detailed analysis using noninvasive or invasive methods is needed to determine the direct association between hepatic fibrosis and steatosis and MetS. In addition, multi-ethnic-group studies would give us more concrete data regarding the impact of MetS on hepatic fibrosis and steatosis and improve the generalizability of these findings across various populations.
{"title":"Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61-9).","authors":"Young-Gyun Seo","doi":"10.7570/jomes22049","DOIUrl":"https://doi.org/10.7570/jomes22049","url":null,"abstract":"J Obes Metab Syndr 2022;31:350-351 Nonalcoholic fatty liver disease has a worldwide prevalence of 25%, which includes diseases ranging from steatosis to steatohepatitis, and has a bidirectional association with metabolic syndrome (MetS).1 Although a few studies have investigated the association between liver fibrosis and MetS, their findings have been controversial. A recent cohort study of a large patient-centered medical home found that a heavy burden of MetS components was associated with high or indeterminate risk for advanced fibrosis when noninvasive indices were used.2 The results of studies evaluating fibrosis confirmed by liver biopsy were different. MetS was not significantly related to advanced liver fibrosis in biopsy-proven metabolic dysfunction-associated fatty liver disease patients3 and MetS was not associated with hepatic fibrosis among individuals with hereditary hemochromatosis.4 Gangireddy et al.5 reported useful findings in an article entitled “Hepatic fibrosis and steatosis in metabolic syndrome.” In analysis using National Health and Nutrition Examination Survey (NHANES) data, 26% of the participants had steatosis; 7.5% had fibrosis; and 3.3% had fibrosis without steatosis. The adjusted odds ratios were 4.12 for steatosis, 3.34 for fibrosis, and 2.67 for fibrosis without steatosis in participants with MetS compared to those without. The strength of Gangireddy et al.’s study5 is that it was population-scale study conducted in the United States. It also has some strengths in that hepatic fibrosis and steatosis were evaluated through liver ultrasound. However, as mentioned in the paper, the fact that hepatic fibrosis and steatosis were not evaluated by liver biopsy is one limitation, and it is necessary to consider a method to address this weakness. Another limitation is that noninvasive indices were not used. By using hepatic fibrosis and steatosis indices such as fatty liver index6 and fibrosis-4 index7 instead of or in addition to liver ultrasound, which was employed only during specific years of the NHANES dataset, the study period could be significantly extended, and a large-scale evaluation of the general population would be possible. Nevertheless, as a study targeting the general population in the United States, Gangireddy et al.’s study5 is meaningful and proves a relationship between hepatic fibrosis and steatosis and MetS. Therefore, further detailed analysis using noninvasive or invasive methods is needed to determine the direct association between hepatic fibrosis and steatosis and MetS. In addition, multi-ethnic-group studies would give us more concrete data regarding the impact of MetS on hepatic fibrosis and steatosis and improve the generalizability of these findings across various populations.","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"350-351"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/1f/jomes-31-4-350.PMC9828699.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Gangwon Obesity and Metabolic Syndrome Study: Methods and Initial Baseline Data. 江原肥胖和代谢综合征研究:方法和初始基线数据。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22064
Yoon Jeong Cho, Sohyun Park, Sung Soo Kim, Hyo Jin Park, Jang Won Son, Tae Kyung Lee, Sangmo Hong, Jee-Hyun Kang, Seon Mee Kim, Yang-Hyun Kim, Won Jun Kim, Young Eun Seo, Yoosuk An, Sang Youl Rhee, Suk Chon, Sookyoung Jeon, Kyungho Park, Bong-Soo Kim, Chang Beom Lee, Kyoung-Kon Kim, Jung Eun Lee

Background: The prevalence of obesity has been continuously increasing, especially in rural areas of South Korea. Therefore, it is important to examine various genetic, behavioral, and environmental factors associated with obesity in these rural areas. The Korean Society for the Study of Obesity commenced a community-based prospective cohort study of the Gangwon area called the Gangwon Obesity and Metabolic Syndrome (GOMS) study to investigate longitudinal changes in the status of obesity and its related factors.

Methods: A total of 317 adults 40-69 years of age were recruited from Hongcheon and Inje districts, Gangwon province, as part of the first wave of this cohort study. Information on participants' demographic, behavioral, psychological, dietary, and environmental factors and past medical histories were collected by self-administered questionnaires and interviewer-administered questionnaires. Anthropometric measurements, blood tests, and a hand grip strength test were performed, and skin keratin and stool samples were collected. Among the 317 enrolled subjects, two participants who did not have anthropometric data were excluded from the data analyses, resulting in an inclusion of a total of 315 participants.

Results: The mean age of the 315 participants in the GOMS initial baseline survey was 58.5 years old, 87 of them were men, and the mean body mass index was 24.7±3.7 kg/m2. Among all participants, 48.9% had hypertension, 21.4% had diabetes mellitus (DM), 55.6% had dyslipidemia, and 46.0% had metabolic syndrome (MS). Both the prevalence rates of DM and MS were significantly higher in men.

Conclusion: The first baseline survey of the GOMS study was initiated, and a more detailed analysis of respondents' data is expected to be continued. Further follow-up and additional recruitment will allow the investigation of risk factors and the etiology of obesity and its comorbidities in rural areas of Gangwon province.

背景:韩国的肥胖患病率持续上升,尤其是在农村地区。因此,研究与这些农村地区肥胖有关的各种遗传、行为和环境因素是很重要的。韩国肥胖研究学会在江原地区开展了一项以社区为基础的前瞻性队列研究,名为江原肥胖和代谢综合征(GOMS)研究,以调查肥胖状况的纵向变化及其相关因素。方法:作为第一波队列研究的一部分,从江原道洪川和仁济地区招募了317名40-69岁的成年人。参与者的人口统计、行为、心理、饮食、环境因素和既往病史信息通过自我填写的问卷和访谈者填写的问卷收集。进行了人体测量、血液测试和手握力测试,并收集了皮肤角蛋白和粪便样本。在317名入组受试者中,2名没有人体测量数据的受试者被排除在数据分析之外,共纳入315名受试者。结果:GOMS初始基线调查315名参与者的平均年龄为58.5岁,其中男性87人,平均体重指数为24.7±3.7 kg/m2。在所有参与者中,48.9%患有高血压,21.4%患有糖尿病,55.6%患有血脂异常,46.0%患有代谢综合征。男性糖尿病和多发性硬化症的患病率均明显高于男性。结论:GOMS研究的第一次基线调查已经开始,预计将继续对受访者的数据进行更详细的分析。进一步的随访和额外的招募将允许调查江原道农村地区肥胖及其合并症的危险因素和病因。
{"title":"The Gangwon Obesity and Metabolic Syndrome Study: Methods and Initial Baseline Data.","authors":"Yoon Jeong Cho,&nbsp;Sohyun Park,&nbsp;Sung Soo Kim,&nbsp;Hyo Jin Park,&nbsp;Jang Won Son,&nbsp;Tae Kyung Lee,&nbsp;Sangmo Hong,&nbsp;Jee-Hyun Kang,&nbsp;Seon Mee Kim,&nbsp;Yang-Hyun Kim,&nbsp;Won Jun Kim,&nbsp;Young Eun Seo,&nbsp;Yoosuk An,&nbsp;Sang Youl Rhee,&nbsp;Suk Chon,&nbsp;Sookyoung Jeon,&nbsp;Kyungho Park,&nbsp;Bong-Soo Kim,&nbsp;Chang Beom Lee,&nbsp;Kyoung-Kon Kim,&nbsp;Jung Eun Lee","doi":"10.7570/jomes22064","DOIUrl":"https://doi.org/10.7570/jomes22064","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of obesity has been continuously increasing, especially in rural areas of South Korea. Therefore, it is important to examine various genetic, behavioral, and environmental factors associated with obesity in these rural areas. The Korean Society for the Study of Obesity commenced a community-based prospective cohort study of the Gangwon area called the Gangwon Obesity and Metabolic Syndrome (GOMS) study to investigate longitudinal changes in the status of obesity and its related factors.</p><p><strong>Methods: </strong>A total of 317 adults 40-69 years of age were recruited from Hongcheon and Inje districts, Gangwon province, as part of the first wave of this cohort study. Information on participants' demographic, behavioral, psychological, dietary, and environmental factors and past medical histories were collected by self-administered questionnaires and interviewer-administered questionnaires. Anthropometric measurements, blood tests, and a hand grip strength test were performed, and skin keratin and stool samples were collected. Among the 317 enrolled subjects, two participants who did not have anthropometric data were excluded from the data analyses, resulting in an inclusion of a total of 315 participants.</p><p><strong>Results: </strong>The mean age of the 315 participants in the GOMS initial baseline survey was 58.5 years old, 87 of them were men, and the mean body mass index was 24.7±3.7 kg/m<sup>2</sup>. Among all participants, 48.9% had hypertension, 21.4% had diabetes mellitus (DM), 55.6% had dyslipidemia, and 46.0% had metabolic syndrome (MS). Both the prevalence rates of DM and MS were significantly higher in men.</p><p><strong>Conclusion: </strong>The first baseline survey of the GOMS study was initiated, and a more detailed analysis of respondents' data is expected to be continued. Further follow-up and additional recruitment will allow the investigation of risk factors and the etiology of obesity and its comorbidities in rural areas of Gangwon province.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"303-312"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/77/a5/jomes-31-4-303.PMC9828700.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handgrip Strength Is Associated with Metabolic Syndrome and Insulin Resistance in Children and Adolescents: Analysis of Korea National Health and Nutrition Examination Survey 2014-2018. 握力与儿童和青少年代谢综合征和胰岛素抵抗相关:2014-2018年韩国国家健康和营养调查分析
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22053
Hae Woon Jung, Jieun Lee, Jaehyun Kim

Background: Reduced handgrip strength (HGS) is associated with adverse cardiometabolic health outcomes. We examined HGS, metabolic syndrome (MetS), and insulin resistance (IR) in children and adolescents.

Methods: The following population-based data from 2,797 participants (aged 10-18 years) of the Korea National Health and Nutrition Examination Survey 2014-2018 were analyzed: complete anthropometric measures, HGS, MetS, and IR (subgroup with fasting insulin, n=555). HGS was analyzed as the combined HGS (CHGS) and the normalized CHGS (nCHGS=CHGS divided by body weight).

Results: At a mean age of 14.4 years, 276 participants (9.9%) had abdominal obesity, 56 (2.0%) had MetS, and 118 (20.9%) had IR. Individual components of MetS and IR were inversely associated with the nCHGS. The odds ratios (ORs) for MetS and IR decreased significantly with higher nCHGS after adjustment for sex, age, physical activity, and sedentary times. The optimal cut-off values that predicted MetS were 0.80 kg/kg (males) and 0.71 kg/kg (females), with significant associations with MetS (OR: 7.4 in males; 5.7 in females) and IR (OR: 3.3 in males; 3.2 in females) observed when nCHGS values were lower than those cut-offs.

Conclusion: HGS is associated with MetS and IR and might be a useful indicator of cardiometabolic risk factors in children and adolescents.

背景:握力降低(HGS)与不良的心脏代谢健康结果相关。我们研究了儿童和青少年的HGS、代谢综合征(MetS)和胰岛素抵抗(IR)。方法:分析2014-2018年韩国国家健康与营养调查的2797名参与者(10-18岁)的以下基于人群的数据:完整的人体测量、HGS、MetS和IR(空腹胰岛素亚组,n=555)。HGS分析为综合HGS (CHGS)和归一化CHGS (nCHGS=CHGS除以体重)。结果:平均年龄14.4岁时,276名参与者(9.9%)患有腹部肥胖,56名(2.0%)患有MetS, 118名(20.9%)患有IR。met和IR的各个成分与nCHGS呈负相关。调整性别、年龄、体力活动和久坐时间后,随着nCHGS的增加,MetS和IR的比值比(ORs)显著降低。预测MetS的最佳临界值分别为0.80 kg/kg(男性)和0.71 kg/kg(女性),与MetS有显著相关性(OR:男性7.4;女性5.7)和IR (OR:男性3.3;当nCHGS值低于这些截断值时,观察到3.2(女性)。结论:HGS与MetS和IR相关,可能是儿童和青少年心脏代谢危险因素的有用指标。
{"title":"Handgrip Strength Is Associated with Metabolic Syndrome and Insulin Resistance in Children and Adolescents: Analysis of Korea National Health and Nutrition Examination Survey 2014-2018.","authors":"Hae Woon Jung,&nbsp;Jieun Lee,&nbsp;Jaehyun Kim","doi":"10.7570/jomes22053","DOIUrl":"https://doi.org/10.7570/jomes22053","url":null,"abstract":"<p><strong>Background: </strong>Reduced handgrip strength (HGS) is associated with adverse cardiometabolic health outcomes. We examined HGS, metabolic syndrome (MetS), and insulin resistance (IR) in children and adolescents.</p><p><strong>Methods: </strong>The following population-based data from 2,797 participants (aged 10-18 years) of the Korea National Health and Nutrition Examination Survey 2014-2018 were analyzed: complete anthropometric measures, HGS, MetS, and IR (subgroup with fasting insulin, n=555). HGS was analyzed as the combined HGS (CHGS) and the normalized CHGS (nCHGS=CHGS divided by body weight).</p><p><strong>Results: </strong>At a mean age of 14.4 years, 276 participants (9.9%) had abdominal obesity, 56 (2.0%) had MetS, and 118 (20.9%) had IR. Individual components of MetS and IR were inversely associated with the nCHGS. The odds ratios (ORs) for MetS and IR decreased significantly with higher nCHGS after adjustment for sex, age, physical activity, and sedentary times. The optimal cut-off values that predicted MetS were 0.80 kg/kg (males) and 0.71 kg/kg (females), with significant associations with MetS (OR: 7.4 in males; 5.7 in females) and IR (OR: 3.3 in males; 3.2 in females) observed when nCHGS values were lower than those cut-offs.</p><p><strong>Conclusion: </strong>HGS is associated with MetS and IR and might be a useful indicator of cardiometabolic risk factors in children and adolescents.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"334-344"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/4f/jomes-31-4-334.PMC9828701.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Promising First Cohort Study in Korean Patients with Obesity and Overweight: Gangwon Obesity and Metabolic Syndrome Study. 韩国肥胖和超重患者的第一队列研究:江原肥胖和代谢综合征研究。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22068
Eun-Jung Rhee
{"title":"The Promising First Cohort Study in Korean Patients with Obesity and Overweight: Gangwon Obesity and Metabolic Syndrome Study.","authors":"Eun-Jung Rhee","doi":"10.7570/jomes22068","DOIUrl":"https://doi.org/10.7570/jomes22068","url":null,"abstract":"","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"285-286"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/7b/jomes-31-4-285.PMC9828706.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10546877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diet Therapy Using a Small Rice Bowl among Japanese Men with Diabetes: A Randomized Controlled Trial. 日本男性糖尿病患者小碗饮食疗法:一项随机对照试验。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22056
Misa Shimpo, Shiori Toga-Sato, Takahiro Tosaki

Background: This study aimed to investigate the effectiveness at 1 and 3 months of using a smaller rice bowl for diet therapy among Japanese men with type 2 diabetes.

Methods: A parallel-group randomized controlled trial was conducted at a medical clinic in Japan. The participants were men with type 2 diabetes mellitus, aged 20-80 years, with glycosylated hemoglobin <8.5%, and who ate rice one or more times per day at home. The intervention group (36 men) received a small rice bowl from which to eat the usual diet therapy, and the control group (38 men) received only the usual diet therapy.

Results: The changes in weight and body mass index among the intervention group at 1 month were significantly higher than those in the control group. There were no significant differences between the two groups at 3 months.

Conclusion: The effects of using a small rice bowl were minor and short-term.

背景:本研究旨在调查日本男性2型糖尿病患者在1个月和3个月时使用较小的饭碗进行饮食治疗的有效性。方法:在日本某医学诊所进行平行组随机对照试验。研究对象为男性2型糖尿病患者,年龄20 ~ 80岁,伴有糖化血红蛋白。结果:干预组患者1个月时体重和体质指数变化明显高于对照组。3个月时两组间无显著差异。结论:使用小碗的效果轻微且短期。
{"title":"Diet Therapy Using a Small Rice Bowl among Japanese Men with Diabetes: A Randomized Controlled Trial.","authors":"Misa Shimpo,&nbsp;Shiori Toga-Sato,&nbsp;Takahiro Tosaki","doi":"10.7570/jomes22056","DOIUrl":"https://doi.org/10.7570/jomes22056","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the effectiveness at 1 and 3 months of using a smaller rice bowl for diet therapy among Japanese men with type 2 diabetes.</p><p><strong>Methods: </strong>A parallel-group randomized controlled trial was conducted at a medical clinic in Japan. The participants were men with type 2 diabetes mellitus, aged 20-80 years, with glycosylated hemoglobin <8.5%, and who ate rice one or more times per day at home. The intervention group (36 men) received a small rice bowl from which to eat the usual diet therapy, and the control group (38 men) received only the usual diet therapy.</p><p><strong>Results: </strong>The changes in weight and body mass index among the intervention group at 1 month were significantly higher than those in the control group. There were no significant differences between the two groups at 3 months.</p><p><strong>Conclusion: </strong>The effects of using a small rice bowl were minor and short-term.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"345-349"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/03/jomes-31-4-345.PMC9828703.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10539850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-perceived Weight and Mortality in Korean Adults Based on the Korea National Health and Nutrition Examination Survey Data Linked to Cause of Death Statistics. 基于与死亡原因统计相关的韩国国家健康和营养检查调查数据的韩国成年人自我感知体重和死亡率。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22051
Kayoung Lee

Background: This study aimed to determine the associations between self-perceived weight, weight perception, and mortality risk among Korean adults.

Methods: Data from the 2007 to 2015 Korea National Health and Nutrition Examination Survey and the 2007 to 2019 Cause of Death Statistics were linked for this cohort study. A complex samples Cox regression analysis involving 42,453 participants (17,056 male; 25,397 female) was performed after excluding those who died within 1 year of the follow-up period, those with a history of cancer, those with cardiovascular diseases, those without body mass index (BMI) data, and those without self-perceived weight data.

Results: During 7.85 years of follow-up, the overall mortality rate was 3.8% (4.5% for male and 3.1% for female). Self-perceived thin weight status was associated with a 43% to 68% higher risk of all-cause mortality and a 2.48-times higher risk of cardiovascular mortality compared to self-perceived just right weight status after controlling for sociodemographic characteristics, health-related behaviors, underlying health status, BMI, and metabolic syndrome. After adjusting for the confounding factors, those who underestimated their weight had a 27% reduced risk of all-cause mortality than those who correctly estimated their weight. The risks of all-cause mortality and cardiovascular mortality were 2.14-times higher and 2.32-times higher, respectively, in the underweight group with an accurate weight estimation than in the normal weight group with an accurate weight estimation. However, all-cause mortality was 47% lower among participants with obesity who overestimated their weight.

Conclusion: Self-perceived thinness and accurately perceived underweight status were associated with increased risks of all-cause mortality and cardiovascular mortality among Korean adults.

背景:本研究旨在确定韩国成年人自我感知体重、体重感知和死亡风险之间的关系。方法:将2007 - 2015年韩国国家健康与营养调查数据和2007 - 2019年死亡原因统计数据进行队列研究。一项涉及42,453名参与者的复杂样本Cox回归分析(17056名男性;25,397名女性)在排除随访期1年内死亡、有癌症病史、有心血管疾病、没有身体质量指数(BMI)数据和没有自我感觉体重数据的患者后进行了研究。结果:在7.85年的随访期间,总死亡率为3.8%(男性4.5%,女性3.1%)。在控制了社会人口统计学特征、健康相关行为、潜在健康状况、BMI和代谢综合征之后,与自我认为体重正常的人相比,自我认为体重过瘦的人全因死亡率风险高出43%至68%,心血管死亡率风险高出2.48倍。在调整了混杂因素后,那些低估自己体重的人比那些正确估计自己体重的人的全因死亡率降低了27%。准确估计体重的体重不足组的全因死亡率和心血管死亡率风险分别比准确估计体重的正常组高2.14倍和2.32倍。然而,高估体重的肥胖参与者的全因死亡率要低47%。结论:在韩国成年人中,自我感知的瘦和准确感知的体重不足与全因死亡率和心血管死亡率的风险增加有关。
{"title":"Self-perceived Weight and Mortality in Korean Adults Based on the Korea National Health and Nutrition Examination Survey Data Linked to Cause of Death Statistics.","authors":"Kayoung Lee","doi":"10.7570/jomes22051","DOIUrl":"https://doi.org/10.7570/jomes22051","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to determine the associations between self-perceived weight, weight perception, and mortality risk among Korean adults.</p><p><strong>Methods: </strong>Data from the 2007 to 2015 Korea National Health and Nutrition Examination Survey and the 2007 to 2019 Cause of Death Statistics were linked for this cohort study. A complex samples Cox regression analysis involving 42,453 participants (17,056 male; 25,397 female) was performed after excluding those who died within 1 year of the follow-up period, those with a history of cancer, those with cardiovascular diseases, those without body mass index (BMI) data, and those without self-perceived weight data.</p><p><strong>Results: </strong>During 7.85 years of follow-up, the overall mortality rate was 3.8% (4.5% for male and 3.1% for female). Self-perceived thin weight status was associated with a 43% to 68% higher risk of all-cause mortality and a 2.48-times higher risk of cardiovascular mortality compared to self-perceived just right weight status after controlling for sociodemographic characteristics, health-related behaviors, underlying health status, BMI, and metabolic syndrome. After adjusting for the confounding factors, those who underestimated their weight had a 27% reduced risk of all-cause mortality than those who correctly estimated their weight. The risks of all-cause mortality and cardiovascular mortality were 2.14-times higher and 2.32-times higher, respectively, in the underweight group with an accurate weight estimation than in the normal weight group with an accurate weight estimation. However, all-cause mortality was 47% lower among participants with obesity who overestimated their weight.</p><p><strong>Conclusion: </strong>Self-perceived thinness and accurately perceived underweight status were associated with increased risks of all-cause mortality and cardiovascular mortality among Korean adults.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"313-324"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/72/jomes-31-4-313.PMC9828707.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10546876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Obesity and Length of COVID-19 Hospitalization: Unexpected Insights from the American Heart Association National COVID-19 Registry. 肥胖与COVID-19住院时间之间的关系:来自美国心脏协会国家COVID-19登记处的意外见解。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-09-30 DOI: 10.7570/jomes22042
William J Collins, Andrew Y Chang, Yingjie Weng, Alex Dahlen, Connor G O'Brien, Jason Hom, Neera Ahuja, Fatima Rodriguez, Nidhi Rohatgi

Background: The mechanism for possible association between obesity and poor clinical outcomes from Coronavirus Disease 2019 (COVID-19) remains unclear.

Methods: We analyzed 22,915 adult COVID-19 patients hospitalized from March 2020 to April 2021 to non-intensive care using the American Heart Association National COVID Registry. A multivariable Poisson model adjusted for age, sex, medical history, admission respiratory status, hospitalization characteristics, and laboratory findings was used to calculate length of stay (LOS) as a function of body mass index (BMI). We similarly analyzed 5,327 patients admitted to intensive care for comparison.

Results: Relative to normal BMI subjects, overweight, class I obese, and class II obese patients had approximately half-day reductions in LOS (-0.469 days, P<0.01; -0.480 days, P<0.01; -0.578 days, P<0.01, respectively).

Conclusion: The model identified a dose-dependent, inverse relationship between BMI category and LOS for COVID-19, which was not seen when the model was applied to critically ill patients.

背景:肥胖与2019冠状病毒病(COVID-19)临床预后不良之间可能存在关联的机制尚不清楚。方法:我们使用美国心脏协会国家COVID-19登记处对2020年3月至2021年4月住院的22915例成人COVID-19患者进行非重症监护分析。采用多变量泊松模型调整年龄、性别、病史、入院呼吸状态、住院特征和实验室结果,计算住院时间(LOS)作为体重指数(BMI)的函数。我们同样分析了5,327名入住重症监护室的患者进行比较。结果:与BMI正常受试者相比,超重、I级肥胖和II级肥胖患者的LOS减少了大约半天(-0.469天)。结论:该模型发现,BMI类别与COVID-19的LOS之间存在剂量依赖的反比关系,而当该模型应用于危重患者时,则没有发现这种关系。
{"title":"Association between Obesity and Length of COVID-19 Hospitalization: Unexpected Insights from the American Heart Association National COVID-19 Registry.","authors":"William J Collins,&nbsp;Andrew Y Chang,&nbsp;Yingjie Weng,&nbsp;Alex Dahlen,&nbsp;Connor G O'Brien,&nbsp;Jason Hom,&nbsp;Neera Ahuja,&nbsp;Fatima Rodriguez,&nbsp;Nidhi Rohatgi","doi":"10.7570/jomes22042","DOIUrl":"https://doi.org/10.7570/jomes22042","url":null,"abstract":"<p><strong>Background: </strong>The mechanism for possible association between obesity and poor clinical outcomes from Coronavirus Disease 2019 (COVID-19) remains unclear.</p><p><strong>Methods: </strong>We analyzed 22,915 adult COVID-19 patients hospitalized from March 2020 to April 2021 to non-intensive care using the American Heart Association National COVID Registry. A multivariable Poisson model adjusted for age, sex, medical history, admission respiratory status, hospitalization characteristics, and laboratory findings was used to calculate length of stay (LOS) as a function of body mass index (BMI). We similarly analyzed 5,327 patients admitted to intensive care for comparison.</p><p><strong>Results: </strong>Relative to normal BMI subjects, overweight, class I obese, and class II obese patients had approximately half-day reductions in LOS (-0.469 days, <i>P</i><0.01; -0.480 days, <i>P</i><0.01; -0.578 days, <i>P</i><0.01, respectively).</p><p><strong>Conclusion: </strong>The model identified a dose-dependent, inverse relationship between BMI category and LOS for COVID-19, which was not seen when the model was applied to critically ill patients.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 3","pages":"277-281"},"PeriodicalIF":5.2,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9d/34/jomes-31-3-277.PMC9579478.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Regulation of Adipose Tissue Biology by Long-Chain Fatty Acids: Metabolic Effects and Molecular Mechanisms 长链脂肪酸对脂肪组织生物学的调控:代谢效应和分子机制
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-06-13 DOI: 10.7570/jomes22014
Sunhye Shin
Long-chain fatty acids (LCFA) modulate metabolic, oxidative, and inflammatory responses, and the physiological effects of LCFA are determined by chain length and the degree of saturation. Adipose tissues comprise multiple cell types, and play a significant role in energy storage and expenditure. Fatty acid uptake and oxidation are the pathways through which fatty acids participate in the regulation of energy homeostasis, and their dysregulation can lead to the development of obesity and chronic obesity-related disorders, including type 2 diabetes, cardiovascular diseases, and certain types of cancer. Numerous studies have reported that many aspects of adipose tissue biology are influenced by the number and position of double bonds in LCFA, and these effects are mediated by various signaling pathways, including those regulating adipocyte differentiation (adipogenesis), thermogenesis, and inflammation in adipose tissue. This review aims to describe the underlying molecular mechanisms by which different types of LCFA influence adipose tissue metabolism, and to further clarify their relevance to metabolic dysregulation associated with obesity. A better understanding of the effects of LCFA on adipose tissue metabolism may lead to improved nutraceutical strategies to address obesity and obesity-associated diseases.
长链脂肪酸(LCFA)调节代谢、氧化和炎症反应,LCFA的生理作用由链长和饱和程度决定。脂肪组织包括多种细胞类型,在能量储存和消耗中发挥着重要作用。脂肪酸摄入和氧化是脂肪酸参与调节能量稳态的途径,其失调可导致肥胖和慢性肥胖相关疾病的发展,包括2型糖尿病、心血管疾病和某些类型的癌症。许多研究报道,脂肪组织生物学的许多方面都受到LCFA中双键的数量和位置的影响,这些影响是由各种信号通路介导的,包括调节脂肪细胞分化(脂肪生成)、产热和脂肪组织炎症的信号通路。这篇综述旨在描述不同类型的LCFA影响脂肪组织代谢的潜在分子机制,并进一步阐明它们与肥胖相关的代谢失调的相关性。更好地了解LCFA对脂肪组织代谢的影响可能会导致改善营养策略,以解决肥胖和肥胖相关疾病。
{"title":"Regulation of Adipose Tissue Biology by Long-Chain Fatty Acids: Metabolic Effects and Molecular Mechanisms","authors":"Sunhye Shin","doi":"10.7570/jomes22014","DOIUrl":"https://doi.org/10.7570/jomes22014","url":null,"abstract":"Long-chain fatty acids (LCFA) modulate metabolic, oxidative, and inflammatory responses, and the physiological effects of LCFA are determined by chain length and the degree of saturation. Adipose tissues comprise multiple cell types, and play a significant role in energy storage and expenditure. Fatty acid uptake and oxidation are the pathways through which fatty acids participate in the regulation of energy homeostasis, and their dysregulation can lead to the development of obesity and chronic obesity-related disorders, including type 2 diabetes, cardiovascular diseases, and certain types of cancer. Numerous studies have reported that many aspects of adipose tissue biology are influenced by the number and position of double bonds in LCFA, and these effects are mediated by various signaling pathways, including those regulating adipocyte differentiation (adipogenesis), thermogenesis, and inflammation in adipose tissue. This review aims to describe the underlying molecular mechanisms by which different types of LCFA influence adipose tissue metabolism, and to further clarify their relevance to metabolic dysregulation associated with obesity. A better understanding of the effects of LCFA on adipose tissue metabolism may lead to improved nutraceutical strategies to address obesity and obesity-associated diseases.","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 1","pages":"147 - 160"},"PeriodicalIF":5.2,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44494491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Triglyceride–Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study 甘油三酯-葡萄糖指数预测代谢不健康肥胖人群心血管结局:一项全国性人群队列研究
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-06-13 DOI: 10.7570/jomes21086
Y. Cho, Hwi Seung Kim, J. Park, W. Lee, Ye-Jee Kim, C. Jung
Background This study assesses the prognostic value of the triglyceride–glucose (TyG) index for cardiovascular (CV) risk in subgroups based on metabolic health and obesity status. Methods Originally, 514,866 participants were enrolled from the Korean National Health Insurance Service-National Health Screening Cohort. The study participants were categorized into four groups: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). The TyG index was calculated using the following formula: ln (fasting triglyceride [mg/dL]×fasting plasma glucose [mg/dL]/2). Participants were followed from 2009 to 2015 for CV events and CV mortality according to the TyG index. Results After exclusions, the final study cohort contained 292,206 people. During the follow-up, 9,138 CV events and 1,163 CV deaths were documented. When the high and low TyG groups were compared, the high TyG group had a substantially increased risk of CV events among the MUNO and MUO participants (multivariable-adjusted hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.07–1.30 and 1.27 [1.14–1.42], respectively). In participants with MUO status, CV mortality was also significantly increased in the high TyG group compared with the corresponding low TyG group (multivariable-adjusted HR, 1.48; 95% CI, 1.13–1.93). In contrast, a high TyG index was not related to CV mortality in the MHNO, MHO, and MUNO groups. Conclusion The predictive value of the TyG index can vary across populations. Among MUO participants, the TyG index was significantly and positively correlated with unfavorable CV outcomes.
本研究评估了基于代谢健康和肥胖状况的亚组中甘油三酯-葡萄糖(TyG)指数对心血管(CV)风险的预后价值。方法最初,从韩国国民健康保险服务-国民健康筛查队列中招募了514,866名参与者。研究参与者被分为四组:代谢健康的非肥胖(MHNO)、代谢不健康的非肥胖(MUNO)、代谢健康的肥胖(MHO)和代谢不健康的肥胖(MUO)。TyG指数计算公式如下:ln(空腹甘油三酯[mg/dL]×fasting血浆葡萄糖[mg/dL]/2)。根据TyG指数,从2009年到2015年随访参与者的CV事件和CV死亡率。排除后,最终的研究队列包含292206人。在随访期间,记录了9138例CV事件和1163例CV死亡。当比较高、低TyG组时,高TyG组在MUNO和MUO参与者中CV事件的风险显著增加(多变量校正风险比[HR], 1.18;95%置信区间[CI]分别为1.07-1.30和1.27[1.14-1.42])。在MUO状态的参与者中,高TyG组的CV死亡率也显著高于相应的低TyG组(多变量校正HR, 1.48;95% ci, 1.13-1.93)。相反,高TyG指数与MHNO、MHO和MUNO组的CV死亡率无关。结论TyG指数在不同人群中具有不同的预测价值。在MUO参与者中,TyG指数与不利的CV结果显著正相关。
{"title":"Triglyceride–Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study","authors":"Y. Cho, Hwi Seung Kim, J. Park, W. Lee, Ye-Jee Kim, C. Jung","doi":"10.7570/jomes21086","DOIUrl":"https://doi.org/10.7570/jomes21086","url":null,"abstract":"Background This study assesses the prognostic value of the triglyceride–glucose (TyG) index for cardiovascular (CV) risk in subgroups based on metabolic health and obesity status. Methods Originally, 514,866 participants were enrolled from the Korean National Health Insurance Service-National Health Screening Cohort. The study participants were categorized into four groups: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). The TyG index was calculated using the following formula: ln (fasting triglyceride [mg/dL]×fasting plasma glucose [mg/dL]/2). Participants were followed from 2009 to 2015 for CV events and CV mortality according to the TyG index. Results After exclusions, the final study cohort contained 292,206 people. During the follow-up, 9,138 CV events and 1,163 CV deaths were documented. When the high and low TyG groups were compared, the high TyG group had a substantially increased risk of CV events among the MUNO and MUO participants (multivariable-adjusted hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.07–1.30 and 1.27 [1.14–1.42], respectively). In participants with MUO status, CV mortality was also significantly increased in the high TyG group compared with the corresponding low TyG group (multivariable-adjusted HR, 1.48; 95% CI, 1.13–1.93). In contrast, a high TyG index was not related to CV mortality in the MHNO, MHO, and MUNO groups. Conclusion The predictive value of the TyG index can vary across populations. Among MUO participants, the TyG index was significantly and positively correlated with unfavorable CV outcomes.","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 1","pages":"178 - 186"},"PeriodicalIF":5.2,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42137521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Retraction: Birth Weight Predicts Anthropometric and Body Composition Assessment Results in Adults: A Population-Based Cross-Sectional Study (J Obes Metab Syndr 2021;30:279-88) 退缩:出生体重预测成年人的人体测量和身体成分评估结果:一项基于人群的横断面研究(肥胖代谢综合杂志2021;30:279-88)
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-06-09 DOI: 10.7570/jomes22039
I. Salmi, S. Hannawi
{"title":"Retraction: Birth Weight Predicts Anthropometric and Body Composition Assessment Results in Adults: A Population-Based Cross-Sectional Study (J Obes Metab Syndr 2021;30:279-88)","authors":"I. Salmi, S. Hannawi","doi":"10.7570/jomes22039","DOIUrl":"https://doi.org/10.7570/jomes22039","url":null,"abstract":"","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 1","pages":"198 - 198"},"PeriodicalIF":5.2,"publicationDate":"2022-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43261831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obesity & Metabolic Syndrome
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1